Upadacitinib 30mg Tablets$87.00
1–9 boxes
$87.00 each
10–24 boxes
8% off
25+ boxes
10% off
Upadacitinib 30mg Tablets
SKU GME529Product Introduction
Upadacitinib 30mg is an oral extended-release Janus kinase (JAK) inhibitor used for selected immune-mediated inflammatory diseases, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, atopic dermatitis, ulcerative colitis, and Crohn's disease depending on approval, severity, prior therapy, and prescribed dose. It reduces inflammatory signaling by selectively inhibiting JAK pathways. Avoid live vaccines during treatment.
How to use
Swallow Upadacitinib 30mg whole once daily or as prescribed. Do not crush, split, or chew extended-release tablets, and do not start during an active serious infection.
How it works
Upadacitinib inhibits JAK-mediated cytokine signaling, reducing immune-driven inflammation in selected inflammatory diseases.
Common side effects
Possible effects include upper respiratory infection, nausea, acne, headache, fever, cough, herpes zoster, raised cholesterol, and lab changes. Serious concerns include severe infection, TB, malignancy, MACE, thrombosis, GI perforation, liver injury, low blood counts, and allergic reaction.
Important information
Review infection symptoms, TB/hepatitis screening, vaccines, CBC, liver tests, lipids, cardiovascular risk, smoking, cancer history, clot history, diverticulitis, pregnancy, breastfeeding, CYP3A4 inhibitors/inducers, and other immunosuppressants.
Uses
Selected immune-mediated inflammatory diseases when upadacitinib is prescribed.
Benefits
Can reduce inflammation, symptoms, and flares in eligible patients after appropriate screening and monitoring.
What is Upadacitinib 30mg used for?
Upadacitinib 30mg is used for selected inflammatory immune conditions depending on diagnosis, dose, and prior therapy.
Why are screening tests needed?
Testing helps identify infection, blood-count, liver, lipid, and safety risks before and during treatment.
Can tablets be split?
Extended-release upadacitinib tablets should be swallowed whole unless the exact product instructions say otherwise.
What infection symptoms matter?
Fever, persistent cough, shingles rash, painful urination, wounds, or feeling very unwell should be reported promptly.
Are live vaccines allowed?
Live vaccines are generally avoided during therapy; vaccination should be reviewed before starting.
Upadacitinib extended-release, JAK inhibitor, Rinvoq alternative, Serious infection boxed warning, TB screening, Thrombosis warning, AR: Upadacitinib أقراص, FR: Upadacitinib comprimé, PT: Upadacitinib comprimido, ES: Upadacitinib tableta, RU: Upadacitinib таблетки, ID: Upadacitinib, VI: Upadacitinib viên nén, MS: Upadacitinib, TL: Upadacitinib tableta, ZH-SG: Upadacitinib 片剂